Slide 1: USCOM Broker Briefings September 2009
For personal use only USCOM (ASX: UCM) Broker Briefings SEPTEMBER 2009 www.uscom.com.au The Measure of Life
Slide 2: USCOM – Summary
For personal use only USCOM – Summary • Medical device Company with emerging “gold standard” heart monitor with multiple clinical applications • 70% revenue growth last fin. year, cash flow break even in Q4 2009, and ready to rapidly grow sales through our US based global partner • Further growth op
Slide 3: Business Milestones
For personal use only Business Milestones • Jan 2007 – Paul Butler appointed CEO, Daniel Fah appointed CFO, and Nick Schicht appointed General Manager • New executive team proposed and implemented restructuring of business and new strategic US objectives • Operational restructure - cost reduced from
Slide 4: Strategic Partnership
For personal use only Strategic Partnership Spacelabs Healthcare Developer, manufacturer and distributor of medical equipment and services: - Spacelabs has exclusive distribution of the USCOM 1A in the Americas, Europe, Middle East, Africa, India, Australia (Medtel) for the in hospital market OSI Sy
Slide 5: USCOM – Applications
For personal use only USCOM – Applications Current applications – In Hospital market • Sepsis • Post cardiac surgery • Nurse led CO measurement • Anesthesia monitoring • ED trauma resuscitation • Liver transplantation Unpartnered applications - New Markets • Electrophysiology –potential partners suc
Slide 6: USCOM – Investment
For personal use only USCOM – Investment SPP • Offer to existing shareholders to purchase up to $15,000 worth of shares at $0.63 • Looking to raise up to $1.26M • As at 30 June 2009 Uscom had cash reserves of $1.9M Use of Funds • Increase our capability to support our global distribution partners o
Slide 7: Key Financial Achievements
For personal use only Key Financial Achievements $1,613k $ -599 www.uscom.com.au The Measure of Life
Slide 8: Key Financial Achievements
For personal use only Key Financial Achievements www.uscom.com.au The Measure of Life
Slide 9: Key Financial Achievements
For personal use only Key Financial Achievements www.uscom.com.au The Measure of Life
Slide 10: Primary product – USCOM 1A
For personal use only Primary product – USCOM 1A www.uscom.com.au The Measure of Life
Slide 11: USCOM – Standard of Care
For personal use only USCOM – Standard of Care Fluid - “The change in SV with PLR was the only haemodynamic index with significant predictive ability” 91% +ve predictive value. Critical Care 2009;13:R111 ICU/PAC – “USCOM.. may safely replace PAC in many clinical situations that call for advanced hem
Slide 12: Emerging standard of care peer reviewed publications and presentations
For personal use only Emerging standard of care 135 peer reviewed publications and presentations 17 Papers and 29 articles, abstracts and posters FY09 Emergency, Pediatrics, Cardiac transplantation, Electrophysiology, Heart Failure, Emergency transport, Anesthesia, Liver transplantation, ICU, Septic
Slide 13: IP - Adding value
For personal use only IP - Adding value USCOM has significant value in patent protected IP 24 patent applications 18 granted patents 11 different applications 2 new US patents since June 2008 Peter Treloar, Patent Attorney, Uscom Patent Report Building a product pipeline…. www.uscom.com.au The Measu
Slide 14: Share price
For personal use only Share price 09 Spacelabs partnership FY Share Price Revenue Cap value 2008 0.18 $0.984m $6.84m 2009 0.77 $1.630m $30.8m www.uscom.com.au The Measure of Life
Slide 15: Market Performance
For personal use only Market Performance PWC BioForum Ed. 29 Q4 FY2009 www.uscom.com.au The Measure of Life
Slide 16: Equity Structure
For personal use only Equity Structure Listed: Dec 2003 (ASX Code: UCM) Total Issued shares: 40,000,000 SPP Maximum issue: 2,000,000 Top 5 shareholders: 70% of shares ROBERT ALLAN PHILLIPS 16,590,000 GARY DESMOND DAVEY 6,000,000 BELL POTTER NOMINEES LTD <BB NOMINEES A/C> 2,124,836 OSI SYSTEMS 2,000,
Slide 17: USCOM – Summary
For personal use only USCOM – Summary • Medical device Company with emerging “gold standard” heart monitor with multiple clinical applications • 70% revenue growth last fin. year, cash flow break even in Q4 2009, and ready to rapidly grow sales through our US based global partner • Further growth op
Slide 18: For personal use only
For personal use only www.uscom.com.au The Measure of Life